Kyodo Pharmaceutical: Pre-disclosure Notice on Reduction of Shareholdings by Shareholders, Directors and Supervisors Holding 5% or More of Their Shares

SZSI · Apr 10

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.